<DOC>
	<DOCNO>NCT00333476</DOCNO>
	<brief_summary>Age-Related Macular Degeneration ( AMD ) degenerative eye disease retina cause progressive loss central vision . AMD lead cause legal blindness among adult age 50 old Western world . AMD present two different type - `` dry '' severe `` wet '' form . Wet AMD cause growth abnormal blood vessel macula . Squalamine lactate investigational drug may prevent growth abnormal blood vessel . This study test safety efficacy Squalamine treatment AMD .</brief_summary>
	<brief_title>A Study MSI-1256F ( Squalamine Lactate ) To Treat `` Wet '' Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Squalamine</mesh_term>
	<criteria>Adult subject â‰¥ 50 year age . minimally classic active occult choroidal neovascularization associate agerelated macular degeneration one eye . baseline best correct visual acuity score 35 65 letter accord Early Treatment Diabetic Retinopathy Study protocol . central retinal thickness optical coherence tomography &gt; 250 micron . lesion &gt; 9 disc area . &gt; 25 % fibrosis lesion . Previous history triamcinolone , bevacizumab , ranibizumab , pegaptanib sodium injection therapy study eye . retinal optic nerve disease . uncontrolled diabetes . ongoing malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>